![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00040066 |
The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Procedure: Cocaine (IV) |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Placebo Control, Parallel Assignment |
Official Title: | Development of Human Laboratory Study Model of Cocaine Relapse Prevention |
Estimated Enrollment: | 32 |
Study Start Date: | May 2002 |
Estimated Study Completion Date: | August 2003 |
The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Please contact site directly for details.
United States, California | |
UCLA Integrated Substance Abuse Program | |
Los Angeles, California, United States, 90024 | |
United States, Texas | |
University of Texas Health Science Center | |
San Antonio, Texas, United States, 78284 |
Principal Investigator: | John Roache, Ph.D. | National Institute on Drug Abuse (NIDA) |
Study ID Numbers: | NIDA-CTO-0013-1 |
Study First Received: | June 18, 2002 |
Last Updated: | October 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00040066 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Cocaine-Related Disorders Dopamine Uptake Inhibitors Neurotransmitter Agents Central Nervous System Depressants Disorders of Environmental Origin Anesthetics Cardiovascular Agents Anesthetics, Local |
Dopamine Mental Disorders Substance-Related Disorders Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Cocaine |
Cocaine-Related Disorders Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Central Nervous System Depressants Anesthetics Disorders of Environmental Origin Cardiovascular Agents Anesthetics, Local |
Pharmacologic Actions Sensory System Agents Mental Disorders Therapeutic Uses Substance-Related Disorders Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Cocaine Central Nervous System Agents |